jurnalul român de psihofarmacologie romanian journal of ...

215. Hori M, Suzuki M, Shiraishu H, Kozumi J. Convulsive seizures in schizophrenic patients
induced by zotepine administration. Jpn Psychiat Neurol 1992; 46:161-167.
216. Prakash A, Lamb HN. Zotepine. A review of its pharmacodynamic and pharmacokinetic
properties and therapeutic efficacy in the management of schizophrenia. CNS Drugs 1998;
9:153-175.
217. Petrie JL, Saha AR, McEvoy JP. Acute and long-term efficacy and safety of aripiprazole: a
new atypical antipsychotic. Schizophr Res 1998; 29:155.
218. Toru M, Miura S, Kudo Y. Clinical experiences of OPC-14597, a dopamine autoreceptor
agonist in schizophrenic patients. Neuropsychopharmacology 1994; 10:122S.
219. Kikuchi T, Tottori K, Uwahodo, Y, Hirose T, Miwa T, Oshiro Y, Morita S. 7-(4-[4-(2,3-
Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1-H)-quinolyne(OPC-14597), a
new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic
activity and postsynaptic D2 receptor antagonistic activity. J Pharmacol Exp Ther 1995;
274:329-336.
220. Semba J, Watanabe A, Kito S, Toru M. Behavioural and neurochemical effects of OPC-
14597, a novel antipsychotic drug, on dopaminergic mechanisms in rat brain.
Neuropharmacology 1995; 34:785-791.
221. Lawler CP, Prioleau C, Lewis MM, Mak C, Jiang D, Schetz JA, Gonzales AM, Sibl DR,
Mailman RB. Interactions of the novel antipsychotic aripiprazole (OPC-14597) with
dopamine and serotonin receptor subtypes. Neuropsychopharmacology 1999; 20:612-627.
222. Momiyama T, Amano T, Todo N, Sasa M. Inhibition by a putative antipsychotic
quinolinone derivative (OPC-14597) of dopaminergic neurons in the ventral tegmental
area. Eur J Pharmacol 1996; 310:1-8.
223. Inoue A, Seto M, Sugita S, Hide I, Hirose T, Koga N, Kikuchi T, Nakata Y. Differential
effects on D2 dopamine receptor and prolactin gene expression by haloperidol and
aripiprazole in the rat pituitary. Molecular Brain Res 1998; 55:285-292.
224. Oshiro Y, Sato S, Kurahashi N, Tanaka T, Kikuchi T, Tottori K, Uwahodo Y, Nishi T.
Novel antipsychotic agent with dopamine autoreceptor agonist properties: synthesis and
pharmacology of 7-[4-(4-phenyl-1-piperazinyl)butoxy]-3,4-dihydro-2(1H) quinolinone
derivatives. J med Chem 1998; 41:658-667.
225. Szewczak MR, Corbett R, Rush DK, Wilmot CA, Conway PG, Strupczewsky JT, Cornfeldt
M. The pharmacological profile of iloperidone, an novel atypical antipsychotic agent. J
Pharmacol Exp Ther 1995; 274:1404-1413.
226. Koncsamut S, Roehr JE, Cai J, Hartman HB, Weissensee P, Kerman LL, Tang L,
Sandrasatgra A. Iloperidone binding to human and rat dopamine and 5-HT receptors. Eur J
Pharmacol 1996; 317:417-423.
150